Does the FDA think these data justify the first full approval of a covid-19 vaccine? - The BMJ
The FDA should demand adequate, controlled studies with long term follow up, and make data publicly available, before granting full approval to covid-19 vaccines, says Peter Doshi On 28 July [...]More...
